https://www.selleckchem.com/products/pf-543.html
registered at the German Clinical Trial Register (DRKS) DRKS00023457 (05.11.202. The KMU-GO trial is registered at the German Clinical Trial Register (DRKS) DRKS00023457 (05.11.202. Alpha-fetoprotein-negative hepatocellular carcinoma (AFP-NHCC) ( 8.78 ng/mL) have special clinicopathologic characteristics and prognosis. The aim of this study was to apply a new method to establish and validate a new model for predicting the prognosis of patients with AFP-NHCC. A total of 410 AFP-negative patients with clinical diagnosed with HCC fo
Like
Comment
Share
